Stéphane Depil, founder and CEO of ErVaccine Technologies, will give a talk entitled “Endogenous retroviruses as a source of tumor antigens in solid tumors and acute myeloid leukemia” at International Conference of the Korean Society of Hematology 2022 (scientific session 6 Cell Therapy planned on March 31).
For more information visit: ICKSH 2022